Showing results (141-150 of 259) with videos related to
Sort By:
Pageof 26
Chinese Medical Journal|September 17, 2025
Long-term outcomes of CNCT19 chimeric antigen receptor T-cell therapy in relapsed or refractory aggressive B-cell lymphomaWei Liu, Ting Xie, Zhuoxin Zhang, et al.British Journal of Haematology|February 11, 2020
Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myelomaXuan Wu, Jiliang Xia, Jingyu Zhang, et al.Blood Science (Baltimore, Md.)|August 7, 2023
Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myelomaTeng Fang, Hao Sun, Xiyue Sun, et al.Frontiers in Immunology|October 9, 2024
DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathwaysLanting Liu, Dasen Gong, Hao Sun, et al.Leukemia|April 12, 2024
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myelomaJian Cui, Yuntong Liu, Rui Lv, et al.Leukemia & Lymphoma|February 20, 2019
Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT studyNoemi Horvath, Andrew Spencer, Melita Kenealy, et al.Blood|April 30, 2016
APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironmentYu-Tzu Tai, Chirag Acharya, Gang An, et al.Journal for Immunotherapy of Cancer|March 5, 2024
Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapyHesong Zou, Wei Liu, Xiaojuan Wang, et al.Haematologica|April 24, 2025
The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significance-like behavior predict an exceptionally favorable prognosis in multiple myelomaWenqiang Yan, Chen Qiu, Jieqiong Zhou, et al.Cancer Biology & Medicine|March 12, 2025
Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphomaYi Wang, Yuting Yan, Dandan Shan, et al.Pageof 26